Gutierrez Mauricio A, Mellonig James T, Cochran David L
J Clin Periodontol. 2003 Aug;30(8):739-45. doi: 10.1034/j.1600-051x.2003.00374.x.
The aim of this study was to evaluate the adjunctive use of enamel matrix derivative (EMD) on periodontal healing following nonsurgical periodontal therapy (scaling and root planing - SRP).
The study was performed as an intraindividual, longitudinal trial of 3 months duration with a double-blinded, split-mouth, controlled, and randomized design. Twenty-two patients with moderate to severe chronic periodontitis were enrolled in the study. In each patient, two sites with pocket depths >/=5 mm and with radiographic angular bone defects >3 mm were selected. Baseline examination included measurement of probing pocket depth (PPD) and clinical attachment levels (CAL). The presence or absence of plaque and bleeding on probing at selected sites was also recorded. Following initial examination, full-mouth SRP was performed. Study sites were then treated with 24% EDTA for 2 min, followed by thorough irrigation with sterile saline. The sites were then randomized. The experimental site received subgingival application of enamel matrix derivative (Emdogain, BIORA AB, Malmo, Sweden). The control site received no additional treatment. At 3 months, all sites were re-examined. The response to therapy in experimental and control sites was evaluated, using change in probing depth and CAL as the primary outcome variables. Statistical analysis (paired t-tests) was used to compare response to treatment in control versus experimental sites.
Statistically significant changes in PPD and CAL were seen in both treatment groups from baseline to 3 months. The mean PPD reduction was 2.3+/-0.5 mm for control sites and 2.0+/-0.3 mm for experimental sites. The mean CAL gain was 1.8+/-0.4 mm for control sites, and 1.4+/-0.3 mm for experimental sites. Statistical analysis, however, revealed no significant difference in PPD reduction or CAL gain between experimental and control groups (p>0.4). In addition, no difference was found between treatment groups in bleeding or plaque indices at 3 months.
The findings from the present study do not support the use of EMD during routine, nonsurgical debridement of periodontal pockets as measured 3 months post SRP.
本研究旨在评估釉基质衍生物(EMD)在非手术牙周治疗(龈上洁治和根面平整 - SRP)后对牙周愈合的辅助作用。
本研究采用个体内纵向试验,为期3个月,采用双盲、分口、对照和随机设计。22例中度至重度慢性牙周炎患者纳入研究。在每位患者中,选择两个牙周袋深度≥5 mm且影像学角度骨缺损>3 mm的部位。基线检查包括测量探诊牙周袋深度(PPD)和临床附着水平(CAL)。还记录了所选部位探诊时菌斑的有无及出血情况。初始检查后,进行全口SRP。然后研究部位用24%乙二胺四乙酸(EDTA)处理2分钟,随后用无菌盐水彻底冲洗。然后将这些部位随机分组。试验部位接受龈下应用釉基质衍生物(Emdogain,BIORA AB,瑞典马尔默)。对照部位不接受额外治疗。在3个月时,对所有部位进行重新检查。以探诊深度和CAL的变化作为主要结局变量,评估试验组和对照组对治疗的反应。采用统计分析(配对t检验)比较对照组和试验组对治疗的反应。
从基线到3个月,两个治疗组的PPD和CAL均有统计学意义的变化。对照组的平均PPD减少2.3±0.5 mm,试验组为2.0±0.3 mm。对照组的平均CAL增加1.8±0.4 mm,试验组为1.4±0.3 mm。然而,统计分析显示试验组和对照组之间PPD减少或CAL增加无显著差异(p>0.4)。此外,在3个月时,治疗组之间的出血或菌斑指数也无差异。
本研究结果不支持在SRP后3个月测量时,在常规非手术牙周袋清创术中使用EMD。